Oxycontin and Deafness neurosensory - a phase IV clinical study of FDA data
We study 208,377 people who have side effects when taking Oxycontin. Deafness neurosensory is found, especially among people who are female, 60+ old, have been taking the drug for 1 - 6 months, also take Enbrel and have Rheumatoid arthritis.
The phase IV clinical study analyzes which people take Oxycontin and have Deafness neurosensory. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
208,377 people reported to have side effects when taking Oxycontin.
Among them, 321 people (0.15%) have Deafness neurosensory.
What is Oxycontin?
Oxycontin has active ingredients of oxycodone hydrochloride. It is used in pain. Currently, eHealthMe is studying from 210,311 Oxycontin users.
What is Deafness neurosensory?
Deafness neurosensory is found to be associated with 1,406 drugs and 882 conditions by eHealthMe. Currently, we are studying 4,278 people who have Deafness neurosensory.
Number of Oxycontin and Deafness neurosensory reports submitted per year:
Time on Oxycontin when people have Deafness neurosensory *:
Gender of people who have Deafness neurosensory when taking Oxycontin*:
Age of people who have Deafness neurosensory when taking Oxycontin *:
Common drugs people take besides Oxycontin *:
Common side effects people have besides Deafness neurosensory *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Oxycontin and have Deafness neurosensory?Check whether Deafness neurosensory is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Oxycontin side effects by duration, gender and age:
- Oxycontin side effects (210,311 reports)
Deafness neurosensory treatments and more:
- Deafness neurosensory (4,278 reports)
Common drugs associated with Deafness neurosensory:
All the drugs that are associated with Deafness neurosensory:
- Deafness neurosensory (1,406 drugs)
Common conditions associated with Deafness neurosensory:
- Rheumatoid arthritis: 432 reports
- Osteoporosis: 284 reports
- Pain: 261 reports
- Arthritis: 248 reports
- High blood pressure: 161 reports
- Sleep disorder: 148 reports
- Depression: 116 reports
All the conditions that are associated with Deafness neurosensory:
- Deafness neurosensory (882 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on oxycodone hydrochloride (the active ingredients of Oxycontin) and Oxycontin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Oxycontin and Deafness Neurosensory - now
- Tapentadol Hydrochloride and Zoledronic Acid drug interaction - 2 seconds ago
- Magnesium and Vyndamax drug interaction - 6 seconds ago
- Cetirizine Hydrochloride and Pericarditis - 9 seconds ago
- Santyl and Omeprazole drug interaction - 11 seconds ago
- Estazolam and Nystatin drug interaction - 13 seconds ago
- Plavix and Abscess Neck - 15 seconds ago
- Aleve and Eosinophil Count Increased - 16 seconds ago
- Profen and Avinza drug interaction - 17 seconds ago
- Aredia and Impaired Gastric Emptying - 20 seconds ago